Pulmari Interactions
There are 472 drugs known to interact with Pulmari (brompheniramine / carbetapentane / phenylephrine), along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 37 are major, 432 are moderate, and 3 are minor.
- View all 472 medications that may interact with Pulmari
- View Pulmari alcohol/food interactions (2)
- View Pulmari disease interactions (8)
Most frequently checked interactions
View interaction reports for Pulmari (brompheniramine / carbetapentane / phenylephrine) and the medicines listed below.
- albuterol
- Aspirin Low Strength (aspirin)
- Calcium 600 D (calcium / vitamin d)
- Celebrex (celecoxib)
- Diovan HCT (hydrochlorothiazide / valsartan)
- Dulcolax Stool Softener (docusate)
- flecainide
- Lasix (furosemide)
- Mirapex (pramipexole)
- omeprazole
- One-A-Day 50+ (multivitamin)
- oxygen
- potassium chloride
- Qvar RediHaler (beclomethasone)
- ranitidine
- Singulair (montelukast)
- Spiriva (tiotropium)
- Symbicort (budesonide / formoterol)
- Tylenol PM (acetaminophen / diphenhydramine)
- Ventolin HFA (albuterol)
- verapamil
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vytorin (ezetimibe / simvastatin)
Pulmari alcohol/food interactions
There are 2 alcohol/food interactions with Pulmari (brompheniramine / carbetapentane / phenylephrine).
Pulmari disease interactions
There are 8 disease interactions with Pulmari (brompheniramine / carbetapentane / phenylephrine) which include:
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- BPH
- diabetes
- glaucoma
More about Pulmari (brompheniramine / carbetapentane / phenylephrine)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.